TO
Trustees of Columbia University in the City of New York
13F filer · CIK 0001420995Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$468MU.S. long equity reported on 13F
Positions21 new · 1 closed
Net flow last quarter-$555MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20262 positions | |||||
| $462M | 98.73% | Not reported | -54.8% | Q4 2024 | |
| $5.92M | 1.26% | Not reported | New | Q2 2026 | |
| Q1 2026Reported May 15, 20262 positions | |||||
| $891M | 99.97% | Not reported | +13.0% | Q4 2024 | |
| $302K | 0.03% | 0.81% | New | Q1 2026 | |
| Q4 2025Reported Feb 13, 20262 positions | |||||
| $826M | 99.60% | Not reported | +23.6% | Q4 2024 | |
| $430K | 0.05% | Not reported | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 20257 positions | |||||
| $653M | 99.69% | Not reported | -11.9% | Q4 2024 | |
| $618K | 0.09% | 0.56% | Not reported | Q3 2021 | |
| $473K | 0.07% | 0.18% | Not reported | Q3 2021 | |
| $265K | 0.04% | 1.09% | Not reported | Q4 2024 | |
| RTRAPTRAPT Therapeutics, Inc. | $237K | 0.04% | 0.06% | Not reported | Q4 2020 |
| $224K | 0.03% | 0.05% | 0.0% | Q1 2021 | |
| $210K | 0.03% | 0.48% | Not reported | Q4 2022 | |
Premium opens every quarter this fund has filed